Clinical Trial Update: SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial results for SU011248 in metastatic mucosal melanoma and acral lentiginous melanoma; the study is completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Lentiginous Melanoma
• Mucosal Melanoma

Drugs mentioned

• SU011248

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Mucosal Lentiginous Melanoma, Acral Lentiginous Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2016-12-08